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Local macrophage proliferation in the progression of glomerular and
tubulointerstitial injury in rat anti-GBM glomerulonephritis. The aim of
this study was to examine the contribution of local proliferation in the
development of macrophage accumulation and macrophage-mediated
injury in rat anti-GBM glomerulonephritis. using double immunohisto-
chemistry staining of monocyte/macrophages plus the proliferating cell
nuclear antigen (PCNA) or bromodeoxyuridine (BrdU) incorporation, we
found that the initial accumulation of ED1 macrophages in the kidney on
day 1 of disease was due to an influx of circulating monocytes. However,
large numbers of proliferating macrophages (ED1PCNA cells), includ-
ing mitotic macrophages, were present within the glomerulus and inter-
stitium during disease progression (days 7 to 21), accounting for up to 62%
of the total macrophage population and giving an excellent correlation
with total macrophage accumulation (glomerulus, r = 0.92; interstitium,
r = 0.94; both P < 0.001). These proliferating cells had a monocyte
phenotype (ED1ED2ED3), but this marked proliferative activity was
restricted to the diseased kidney since no PCNA expression or BrdU
incorporation was evident within circulating blood monocytes. Proliferat-
ing macrophages were almost exclusively localized in areas of severe tissue
damage and they correlated significantly with glomerular and tubulointer-
stitial lesions (P < 0.001), proteinuria (P < 0.001) and creatinine
clearance (P < 0.01). In marked contrast, glomerular PCNA macro-
phages failed to correlate with these parameters. In conclusion, this study
has demonstrated that local macrophage proliferation is the major mech-
anism of macrophage accumulation during the progression of rat anti-
GBM glomerulonephritis. Furthermore, it suggests that proliferating
macrophages are potent local effector cells in the mediation of progressive
renal injury in this disease.
Glomerular and interstitial macrophage accumulation is a
feature of most forms of glomerulonephritis, being most promi-
nent in rapidly progressive disease [1, 2]. Studies in animal models
of glomerulonephritis have demonstrated an important role for
macrophages in the induction of renal injury [reviewed in 2—5].
The conventional view of macrophage accumulation during gb-
merulonephritis, and indeed in inflammatory reactions in general,
is that the accumulation arises almost exclusively from the influx
of circulating blood monocytes [6]. However, this view is now
changing in the light of recent animal studies demonstrating
significant increases in the number of proliferating macrophages
within the kidney during acute allograft rejection, immune com-
plex glomerulonephritis and anti-Thy-i disease [7—9]. As yet it is
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not known whether the presence of proliferating macrophages in
the kidney represents local proliferation or the influx of prolifer-
ating cells. Also, the importance of macrophage proliferation in
the progression of renal injury remains to be determined. The
current study has addressed these two questions by examining
monocyte and macrophage proliferation using PCNA expression
(a marker of Gi, S and G2 phases of the cell cycle) [10—12], BrdU
incorporation (a marker of S phase) and the presence of mitotic
figures during the induction and progression of rat anti-gbomeru-
lar basement membrane (GBM) glomerulonephritis.
Methods
Experimental disease
Inbred male Sprague-Dawley rats (150 to 200 g) were obtained
from Monash Animal Services (Melbourne, Australia). Anti-
GBM glomerulonephritis was induced as previously described [13,
14]. Briefly, animals were immunised s.c. with 5 mg normal rabbit
IgG in Freund's complete adjuvant and injected i.v. with 10 ml!kg
body wt rabbit anti-rat GBM serum five days later (termed day 0).
Groups of 6 animals were killed on days 1, 7, 14, and 21. In
addition, two animals in each group were injected intraperitone-
ally with 50 mg/kg 5-bromo-2-deoxyuridine (BrdU) three hours
prior to being killed. A group of six normal animals was used as a
control.
Renal function and proteinuria
Urinary protein excretion (24 hr collections), serum and urine
creatinine levels were determined as previously described [13]. All
analyses were performed in the Department of Biochemistry,
Monash Medical Centre. Data from each group of six animals are
expressed as mean SEM.
Histopathology
Tissues were fixed in formalin and 4 jtm paraffin sections were
stained with hematoxylin and eosin (H&E) or periodic acid-Schiff
(PAS). Glomerular and tububointerstitial damage was scored as
previously described [13, 14]. Briefly, gbomerular hypercellularity
was assessed on the basis of total glomerular cell counts/glomer-
ular cross section (gcs). At least 100 glomeruli per animal were
scored in H&E sections and ranked as: (0), normal (< 50
cells/gcs); (1), mild (60 to 80 cells/gcs); (2), moderate (80 to 120
cells/gcs), and; (3), severe hypercellularity (> 120 cells/gcs). The
percentage of glomeruli exhibiting segmental lesions such as
segmental necrosis, proliferation and sclerosis was assessed by
examining 100 gbomeruli per animal in PAS-stained sections. In
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addition, the percentage of the cortical tubulointerstitium con-
taining focal tubulointerstitial damage such as tubular necrosis
and atrophy, interstitial fibrosis and granuloma formation was
scored.
Immunohistochemistiy
Two and three color immunohistochemistry staining was per-
formed using a newly described microwave-based technique [15].
Briefly, cryostat sections (6 jim) of paraformaldehyde-lysine-
periodate (PLP)-fixed tissues were preincubated with 10% fetal
calf serum (FCS) and 10% normal goat serum in PBS for 20
minutes, drained and labeled with one of the following monoclo-
nal antibodies (niAb): ED1 (monocyte and macrophages), ED2
and ED3 (resident tissue macrophages) [16]; R73 (non-polymor-
phic a13 T cell receptor) [17]; or OX-i (leukocyte common
antigen, anti-CD45) [18], for 60 minutes. Endogenous peroxidase
was inactivated by incubation in 0.3% H202 in methanol, and
sections were labeled with peroxidase-conjugated goat anti-mouse
IgG followed by mouse peroxidase-anti-peroxidase complexes and
developed with 3,3-diaminobenzidine to produce a brown color.
At this point, slides were treated by two rounds of microwave oven
heating, each lasting five minutes, and performed in 0.01 mol/liter
sodium citrate pH 6.0 at 2450 MHz and 800 watts power. This
treatment was used to denature IgG molecules bound to tissue
sections to prevent antibody cross reaction, to improve antibody
access to the cytoplasmic ED1 and nuclear PCNA antigens, and to
denature DNA and thus facilitate mAb access to incorporated
BrdU. Following a second preincubation as above, sections were
then labeled with either PC-b mAb (anti-PCNA) [19], or M744
mAb (anti-BrdU; both from Dako Ltd, Glostrup, Denmark).
After washing in PBS, sections were labeled sequentially with goat
anti-mouse IgG and mouse alkaline phosphatase-anti-alkaline
phosphatase complexes and developed with Fast Blue BB Base
(Sigma Chemical Co., St. Louis, MO, USA). Sections were
counterstained with period acid-Schiff reagent without hematox-
ylin and cover slipped in an aqueous mounting medium. In
addition, cell spots of peripheral blood mononuclear cells pre-
pared by Ficoll-gradient centrifugation from both normal and
diseased animals were double stained as described above.
Paraffin sections (4 jim) were dewaxed, microwaved and then
double stained with ED1 and PC1O or ED1 and BrdU mAbs as
described above. In addition, some sections were triple stained for
ED1, BrdU and PCNA mAbs [15]. As a control, an isotype-
matched irrelevant mAb (73.5; mouse anti-human CD45R) was
used.
It should be noted that microwave treatment markedly en-
hances detection of the PCNA. The standard 1 in 200 dilution of
the PC-b mAb produced non-specific nuclear staining on micro-
wave treated sections. However, this problem was overcome by
using the PC-b mAb at a 1 in 1000 dilution which gave specific
and reproducible staining. This point may explain problems
encountered using this antibody in some other studies [20, 21].
Quantitation of proliferating cells
Labeled cells within PLP-fixed cryostat tissue sections were
scored as previously described [13, 14]. Briefly, the number of
nucleated ED1 macrophages, R73 T cells, and OX-1 total
leukocytes was counted in at least 50 glomerular cross sections per
animal with each cell being assessed for nuclear anti-PCNA or
anti-BrdU staining. The total number of PCNA and BrdU cells
within glomeruli was also counted. Proliferation of intrinsic glomer-
ular cells was assessed by an OX-1PCNA phenotype in double
stained sections. In addition, at least 20 glomeruli per animal were
examined using a point counting technique to quantitate the number
of proliferating (ED1PCNA or ED1BrdU) and non-prolifer-
ating (ED1PCNA or EDiBrdU) macrophages inside and
outside glomerular segmental lesions (necrotic, proliferative, or
sclerotic). In the cortical interstitium, the number of ED1, R73,
ED1PCNA and R73PCNA cells were counted in 50 to 100
consecutive high power fields by means of a 0.02 mm graticule fitted
in the eyepiece of microscope. Data from cell counting are presented
as the mean SEM per glomerular cross section (gcs) or mm2. In
addition, cell spots of blood mononuclear cells were double labeled
for detection of ED1 and BrdU or ED1 and PCNA antigens. The
entire cell spot was examined in each case (approx. 10,000 to 20,000
cells) of which roughly 10% were ED1 monocytes.
Statistical analysis
The number of macrophages and T cells (total, proliferating
and non-proliferating) present during the 21-day time course was
analyzed by one way analysis of variance (ANOVA) using the
Complete Statistical Analysis program (CSS, Statsoft, USA). In
addition, macrophage populations were compared with the sever-
ity of glomerular and tubulointerstitial damage, proteinuria and
creatinine clearance by the Spearman's rank correlation coeffi-
cient. The number of proliferating macrophages inside and out-
side glomerular segmental lesions was compared by the non-
parametric Mann-Whitney U-test.
Results
Macrophage accumulation and proliferation
Macrophage accumulation and proliferation within the kidney
of normal and diseased animals is shown in Table 1. Few
proliferating macrophages (ED1 PCNA cells) were present in
normal rat kidney, accounting for 5% of the total ED1 macro-
phage population. Approximately 5 to 10% of the ED1 popula-
tion expressed ED2 and/or ED3 antigens which mark mature
tissue macrophages, but no PCNA expression was seen in the
ED2 and ED3 populations.
There was a significant increase in the number of glomerular
and interstitial ED1 macrophages on day 1 of anti-GBM disease
with further macrophage accumulation during disease progression
over days 7 to 21 (Table 1). While there was not a significant
increase in ED1PCNA macrophages on day 1 of disease, a
dramatic increase in the number of proliferating macrophages was
evident during disease progression (days 7 to 21). Indeed, prolif-
erating cells accounted for 50 to 61% and 35 to 62% of the total
ED1 macrophage population in the glomerulus and interstitium
over days 7 to 21, respectively. There was an excellent correlation
between numbers of ED1 PCNA cells and the total accumula-
tion of EDi macrophages within both the glomerulus (r = 0.92,
P < 0.001) and interstitium (r = 0.94, P < 0.001) over the entire
time course.
Interestingly, macrophage proliferation within the kidney was
restricted to cells of an ED1ED2ED3 monocyte phenotype,
suggesting that they were recently recruited blood monocytes. In
contrast, no proliferation or increase in the ED2 and ED3
resident interstitial macrophage population was seen throughout
the disease course (2 to 8 cells/mm2) and no ED2 or ED3
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Table 1. Macrophage accumulation, macrophage proliferation, histologic damage and renal injuty during the development of anti-GBM
glomerulonephritis
Glomerulus Interstitium RenaI injuly
ED1 ED1PCNA
cells/gcs cells/gcs
Hypercell.
(0—3)
Seg. lesions
%
ED1
cells/mm2
ED1PCNA
cells/mm2
Tub. lesions
%
Fibrosis
(0—3)
Proteinuria
mg/24 hr
Cr
iinol/1iter
Normal 0.4±0.1 0.02±0.01 0.0±0.0 0.0±0.0 14.5±1.2 1.2±0.2 0.0±0.0 0.0±0.0 4.1±0.8 1.23±0.1
Disease
Dayl
Day7
Dayl4
Day2l
6•206b
10.5
11.4±1.0c
13.2±1.2c
1.4±0.5
5.1
7.0±0.9c
8.0±0.6c
0.9±0.71
2.5 ±0.2c
2.7±0.2
0.0±0.0
12.0± 15b
32.5±4.2c
48.7±5.1c
104±12a
133
19620b
373±67c
20±3.4
46±10
121±21c
217±45c
0.0±0.0
12.7± 1.3
30.2±2.2
46.4±3.5
0.0±0.0
0.5100b
2.7±0.2c
l22±34b
257±27c
428±45c
500±105c
1.15±0.06
1.3
0.92±0.07
0•53006b
Data represent mean SaM for each group of 6 animals. Abbreviations are: Hypercell, hypercellularity; Seg, segmental; Tub, tubular, C, creatinine
clearance.
ap < 0.05; bp < 0.01; C < 0.001, compared to normal rats
macrophages were seen within the glomerulus. To rule out the
possibility that the large number of proliferating ED1ED2ED3
macrophages seen in the diseased kidney arose by recruitment of
proliferating monocytes from the circulation, blood monocytes were
examined. No PCNA expression or BrdU incorporation was de-
tected in blood monocytes in either normal animals or in animals
throughout the disease course.
T cell accumulation and proliferation
Only rare proliferating T cells were evident in normal rat kidney
(Fig. 1). During anti-GBM disease there was a minor transient
glomerular T cell infiltrate which showed almost no proliferative
activity. In contrast, there was marked interstitial accumulation of
T cells during the induction and progression of disease. While
there was an elevation in the number of proliferating T cells in the
interstitium, this did not reach statistical significance.
Localization of proliferating macrophages within the kidney
Glomerular hypercellularity is a prominent feature of rat
anti-GBM glomerulonephritis. Two color immunohistochemistry
showed that the mild glomerular hypercellularity seen on day 1
was primarily due to an influx of ED1PCNA monocytes (Fig.
2A). However, macrophage proliferation was prominent in the
development of severe hypercellularity (Table 1 and Fig. 2B), with
ED1 PCNA cells accounting for 57%, 72% and 65% of total
glomerular PCNA cells on days 7, 14 and 21, respectively.
Mesangial cells and podocytes accounted for the non-leukocytic
OX-1PCNA population of proliferating glomerular cells dur-
ing the disease.
Focal segmental glomerular lesions such as necrotic, prolifera-
tive and sclerotic lesions were first evident on day 7 of the disease
and became progressively more severe (Table 1). Proliferating
macrophages were prominent within glomerular focal segmental
lesions (Fig. 2 C, D). Quantitative analysis showed that 71% of
glomerular macrophages were present within segmental lesions. A
striking finding was that PCNA expression was evident in 70% of
ED 1 macrophages within glomerular segmental lesions, whereas
only 29% of glomerular ED1 macrophages in areas without
segmental lesions were PCNA (Fig. 3). In addition, large
numbers of ED1PCNA macrophages, including multinucle-
ated giant cells, were present within glomerular granulomatous
lesions (Fig. 2F).
To confirm that ED1PCNA macrophages were indeed pro-
gressing through cell division, two approaches were employed.
Firstly, animals were injected with BrdU which is taken up during
01 7
Days after administration of nephrotoxic serum
Fig. 1. T-cell accumulation and prolif eration in rat anti-GBMglomerulone-
phritis. Total R73 T cells (—) and R73PCNA proliferating T cells
(———) in (a) glomerulus, and (b) interstitium. Data are shown as mean
SEM for groups of 6 animals. Each experimental group was compared with
normal animals by one way analysis of variance (ANOVA): < 0.05;
< 0.01; *** < 0.001.
S-phase, a point after the commitment to cell division at the
GuS-phase boundary. All BrdU cells in tissue sections were
double stained with the anti-PCNA mAb. In addition,
ED1BrdU cells accounted for 35% of the ED1PCNA
glomerular macrophage population in the disease. An example of
BrdU-labeled macrophages is shown in Figure 2E. Secondly,
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ED1 macrophages were examined for the presence of mitotic
figures. Occasional mitotic macrophages were found in areas of
focal macrophage accumulation as illustrated in Figure 4A,
demonstrating the completion of macrophage cell division within
the kidney.
Macrophage accumulation within the interstitium was also
predominantly within areas of focal damage. The majority of
macrophages within tubulointerstitial lesions such as focal tubular
necrosis, proliferative lesions, focal tubular destruction and gran-
ulomas were PCNA (Fig. 4 B-E). In contrast, few ED1PCNA
macrophages were evident in intact areas of the interstitium (Fig.
4).
Proliferating macrophages in both the glomerulus and intersti-
tium exhibited a more intense staining reaction with the ED1
mAb (anti-CD68) compared to PCNA macrophages (Figs. 2 and
4). Similarly, there was a significant increase in the intensity of
MHC class II expression by PCNA versus PCNA macrophages
(not shown).
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Correlation of macrophage proliferation with histological damage
and renal injuty
In this study, mild proteinuria was evident during the induction
of disease (day 1) and disease progression was associated with a
fall in creatinine clearance, severe proteinuria and development
of severe glomerular and interstitial lesions over days 7 to 21
(Table 1). To assess the potential of subpopulations of prolifer-
ating and non-proliferating macrophages to mediate renal dam-
age, these populations were correlated with parameters of renal
injury and tissue damage over the entire disease course (Table 2).
The total glomerular ED1 macrophage population correlated
significantly with the severity of glomerular lesions (P < 0.001),
proteinuria (P < 0.001), and the reduction in creatinine clearance
(P < 0.01). A very similar correlation was found with the
glomerular ED1 PCNA subpopulation. However, glomerular
ED1 PCNA macrophages failed to correlate with any of these
parameters (Table 2). In addition, total interstitial EDi macro-
phages also correlated significantly with interstitial lesions, pro-
teinuria and creatinine clearance (P < 0.001). Again, the intersti-
tial ED1 PCNA macrophage subpopulation gave a very similar
correlation. The interstitial ED1 PCNA subpopulation did cor-
relate with all parameters (P < 0.05), but the degree of signifi-
cance of the correlations was substantially lower than that seen for
the total ED1 and ED1PCNA macrophage populations (Ta-
ble 2).
Discussion
The conventional view of macrophage accumulation in glomer-
ulonephritis is of recruitment of blood monocytes into the kidney
with no significant local macrophage proliferation. The current
study has changed this view with the demonstration of high levels
of macrophage proliferation within the kidney during the progres-
sion of rat anti-GBM glomerulonephritis. The presence of such
large numbers of proliferating macrophages together with the
excellent correlation between the accumulation of ED1 PCNA
and total ED1 cells indicates that local proliferation is the major
mechanism of macrophage accumulation during the progression
of this disease model. The results of this study confirm and extend
the findings of recent papers reporting macrophage proliferation
in rat renal allograft rejection, immune complex glomerulonephri-
tis and anti-Thy-i nephritis [7—9]. The four main points arising
from this study are discussed below.
First, proliferating macrophages within the kidney had an
ED1 ED2ED3 — monocyte phenotype, indicating that they were
recently recruited blood monocytes rather than resident tissue
macrophages. The absence of proliferative activity in circulating
monocytes demonstrated that macrophage proliferation within
Fig. 2. Double immunohistochemistty staining of paraffin sections showing macrophage PCNA orBrdU expression and glomerular damage during the
development of rat anti -GBM glomerulonephritis. Brown cytoplasmic staining indicates ED1 macrophages while blue nuclear staining indicates PCNA
or BrdU cells. Arrows indicate ED1 PCNA or ED1 BrdU macrophages, while arrow heads indicate ED1 PCNA or ED1 BrdU macrophages.
(a) Day 1 of disease, showing mild glomerular hypercellularity with some PCNA+ macrophages; (b) day 21, showing many ED1 PCNA macrophages
within a glomerulus with severe hypercellularity; (c) day 7, numerous EDI PCNA macrophages within a segmental necrotic lesion; (d) day 14, many
ED1PCNA macrophages localized within a segmental proliferative/sclerotic lesion; (e) day 14, EDlBrdU macrophages within a segmental
proliferative lesion; (f) day 21, showing many proliferating macrophages, including an ED1PCNA multi-nucleated giant cell (*), within a glomerular
granulomatous lesion. Sections were counterstained with PAS without hematoxylin (X 400). Reproduction of this figure in color was supported by the
Prince Heniy's Hospital Whole Time Medical Specialists' Private Trust Fund.
10 - **
0
U)
(1)
9-
8-
7-
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Segmental Non-segmental
lesions lesions
Fig. 3. Macrophage proliferation within segmental glomerular lesions.
ED1 PCNA proliferating macrophages () and ED1 PCNA non-
proliferating macrophages (El) in segmental and non-segmental glomer-
ular lesions. Data are shown as mean SCM from groups of 18 animals
covering days 7, 14 and 21. ** P < 0.01.
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Fig. 4. Immunohistochemistiy staining of paraffin sections showing
macrophage proliferation and cell division in association with tubuloin-
terstitial damage during the development of rat anti-GBM glomendone-
phritis. (a) Focal accumulation of ED1 macrophages (brown) within
a glomerulus (G) and the tubulointerstitium (TI) on day 14 including
two metaphase macrophages (arrows). Counterstained with hematox-
ylin (x 1000). In (b-e), brown cytoplasmic staining indicates ED1
macrophages while blue nuclear staining indicates PCNA cells.
Examples of ED1PCNA (arrows) and ED1PCNA (arrow heads)
macrophages are indicated in: (b) day 7, numerous ED1PCNA
macrophages within an area of tubular necrosis; (c) day 14, many
ED1PCNA macrophages within a focal proliferative tubulointersti-
tial lesion; (d) day 21, numerous ED1PCNA macrophages within a
severe destructive tubulointerstitial lesion; and (e) day 21, showing a
granulomatous-like lesion with a multinucleated giant cell (*) within
the tubulointerstitium. Sections (b-e) were counterstained with PAS
without hematoxylin (x 400). Reproduction of this figure in color was
supported by the Prince Henry's Hospital Whole Time Medical
Specialists' Private Trust Fund.
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Table 2. Correlation analysis of macrophage subpopulations with histological damage and renal injury
Glomerulus Tubulointerstitium Renal function
Tub. lesion Fibrosis Proteinuria Cc.Hypercell Seg. lesion
Total ED1 Glom
mt
0.817"
—
0.765"
—
—
0.711"
—
0.810C
0.675C
0.651"
ED1PCNA Glom
mt
0.832C
—
0.845"
—
—
0.743"
—
0.809"
0.655"
0.612C —0.619"
ED1PCNA Glom
mt
0.131
—
0.058
—
—
0.570a
—
o.439a
0.223
0.510a
0.054
Each macrophage population was compared with each parameter over the entire day 1-21 time course of rat anti-GBM glomerulonephritis (N = 24)
using Spearman's rank correlation coefficient. Abbreviations are in Table 1 and: Glom, glomerulus; Int, interstitium.
aP < 005, 1P < 0.01, "P c 0.001
the kidney was a localized event. Proliferating macrophages did
not fully differentiate into a mature phenotype since there was no
increase in the number of ED2 or ED3 resident kidney
macrophages during the disease course. This is consistent with
rapid trafficking of macrophages from the kidney to the draining
lymph nodes in this disease model [22] and the relatively small
increase in total macrophage accumulation over days 7 to 21
compared with the large numbers of proliferation cells seen at
these times. However, macrophages did complete cell division
within the kidney as demonstrated by the presence of mitotic
ED1 cells.
Second, macrophage proliferation contributed to severe gb-
merular hypercellularity in this disease. It is widely recognized
that macrophage accumulation contributes to glomerular hyper-
cellularity in proliferative forms of glomerulonephritis, but gb-
merular cell proliferation is thought to be restricted to mesangial
cells [23]. The current study has extended these observations by
demonstrating that macrophages were the major population of
proliferating glomerular cells during the progression of anti-GBM
glomerulonephritis. This highlights the difference in population
kinetics between gbomerular macrophages and mesangial cells in
this disease. However, the population kinetics of macrophage and
mesangial cell proliferation depends upon the nature of the
glomerular insult, as shown by the far greater mesangial prolifer-
ative response in comparison to macrophage proliferation in rat
anti-Thy-i disease [9]. Thus, it is important to employ double
mAb staining to determine the phenotype of proliferating cells
within the glomerulus.
Thirdly, the localization of proliferating macrophages within
areas of severe tissue damage indicates that these cells are either
mediating renal injury or responding to injury. Given the substan-
tial body of evidence demonstrating that macrophages mediate
renal injury in this and other experimental models of glomerulo-
nephritis [2—5], it is reasonable to postulate focal macrophage
accumulation is a cause of tissue injury. In this context, the very
marked difference between the correlation of the ED1PCNA
and ED1PCNA populations with parameters of histologic
damage and renal injury suggests the active participation of
proliferating macrophages in tissue damage. Indeed, the resident
ED2 and ED3 macrophage population did not appear to be
involved in mediation of renal injury in this model. The proposal
that proliferating macrophages induce renal injury is supported by
the increased level of CD68 and MHC class II antigen expression
in ED1PCNA macrophages compared to ED1PCNA cells
which indicates increased lyzosomal activity and an 'activated'
state, respectively [24]. This is also consistent with the significant
correlation between ED1 BrdU glomerular macrophages and
proteinuria in rat immune complex glomerulonephritis [8]. The
proposal that local macrophage proliferation plays a central role
in the development of severe focal lesions is a new concept which
has important implications for how we view the action of macro-
phages in tissue injury and opens up new avenues as to how
macrophage action could be targeted from a therapeutic view-
point. Additional studies are underway to determine whether this
concept is supported by further differences in the functional
capacities of ED1 PCNA and ED1 PCNA macrophage sub-
populations.
An important observation is that the degree of local macro-
phage proliferation correlates with the severity of tissue damage
in different models of kidney injury. Large numbers of proliferat-
ing macrophages are present in severe renal injury such as the
current study of anti-GBM glomerulonephritis and on day 5 of
untreated rat renal allograft rejection [7]. In contrast, a much
lower number of proliferating macrophages are found in disease
models featuring a less severe renal injury, such as rat immune
complex glomerulonephritis and anti-Thy-i nephritis [8, 9]. Thus,
local macrophage proliferation may be of prognostic significance
in human glomerulonephritis.
Fourthly, the question arises as to what mechanisms drive the
strong local macrophage proliferation in this disease? The focal
localization of proliferating cells suggests that local production of
factors which stimulate macrophage proliferation play a central
role in regulating the development of focal lesions. One candidate
molecule which may stimulate local macrophage proliferation is
the well characterized Macrophage-Colony Stimulating Factor
(M-CSF) [25]. Glomerular macrophage accumulation prior to,
and during the progression of, murine lupus nephritis is associated
with increased glomerular M-CSF mRNA expression [26, 27]. In
addition, macrophages isolated from glomeruli during the pre-
proteinuric state remained viable and proliferated in response to
M-CSF in vitro, suggesting that local M-CSF production may
induce glomerular macrophage proliferation and differentiation
during the progression of this disease model [26, 27]. Interferon-y
(IFNy) may also promote macrophage proliferation as shown by
the ability of IFNy treatment to caused a two- to threefold
increase in the number of gbomerular ED1 PCNA macrophages
in rat anti-Thy-i nephritis [9], although it has yet to be determined
whether the increase in macrophage proliferation was a direct
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effect of IFNy. Studies are currently underway to investigate the
mechanisms regulating local macrophage proliferation in rat
anti-GBM glomerulonephritis.
In conclusion, this study has demonstrated that local macro-
phage proliferation is the major mechanism of macrophage
accumulation during the progression of rat anti-GBM glomerulo-
nephritis. In addition, it is proposed that proliferating macro-
phages are potent local effector cells in mediating renal injury.
These findings provide new insights into macrophage-mediated
renal injury and suggest that targeting local macrophage prolifer-
ation could be of therapeutic benefit in glomerulonephritis.
Acknowledgments
This work was funded by NH&MRC grant #930827. Part of this work
was presented at the Annual Meeting of the American Society of
Nephrology, Orlando, 1994. Reproduction of Figures 2 and 4 in color was
supported by the Prince Henry's Hospital Whole Time Medical Special-
ists' Private Trust Fund.
Reprint requests to Dr. Hui Y Lan, Department of Nephrology, Monash
Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia.
References
1. HOOKE DH, GEE DC, ATKINS RC: Leukocyte analysis using mono-
clonal antibodies in human glomerulonephritis. Kidney mt 31:964—
972, 1987
2. MAIN 1W, NIKOLIC-PATERSON DJ, ATKINS RC: T cells and macro-
phages and their role in renal injury. Seminars in Nephrol 12:428—440,
1992
3. NIKOLIC-PATERSON DJ, LAN HY, HILL PA, ATKINS RC: Macrophages
in renal injury. Kidney mt 45(Suppl 45):S79—S82, 1994
4. CArrELL V: Macrophages in acute glomerular inflammation. Kidney
mt 45:945—952, 1994
5. VAN GooR H, DING G, KEES-FOLTS D, GROND J, SCHREINER GF,
DIAMOND JR: Macrophages and renal disease. Lab Invest 71:456—464,
1994
6. VAN FURTH R: Phagocytic cells: development and distribution of
mononuclear phagocytes in normal steady state and inflammation, in
Inflammation: Basic Principles and Clinical Correlates, edited by GAL-
LIN JI, GOLDSTEIN TM, SYNDERMAN R, New York, Raven Press Ltd,
1988, pp 281—295
7. KERR PG, NIKOLIC-PATERSON DJ, LAN HY, RAINONE 5, TESCH G,
ATKINS RC: Deoxyspergualin suppresses local macrophage prolifera-
tion in renal allograft rejection. Transplantation 58:596—601, 1994
8. REN K, BRENTJENS J, CHEN Y, BRODKIN M, NOBLE B: Glomerular
macrophage proliferation in experimental immune complex nephritis.
Clin Immunol Immunopathol 60:384—398, 1991
9. JOHNSON RJ, LOMBARDI D, ENG E, GORDON K, ALPERS CE, PRITZL P,
FLOEGE J, YOUNG B, PIPPIN J, COUSER WG, GABBIANI G: Modulation
of experimental mesangial proliferative nephritis by interferon-y.
Kidney Int 47:62—69, 1995
10. PRELICH G, T C-K, KOSTURA M, MATHEWS MB, So AG, DOWNEY
KM, STILLMAN: Functional identity of proliferating cell nuclear anti-
gen an a DNA polymerase-6 auxiliary protein. Nature 326:517—520,
1987
11. MORRIS GF, MATHEWS MB: Regulation of proliferating cell nuclear
antigen during the cell cycle. J Biol Chem 264:13856—13864, 1989
12. PICH A, PONTI R, VALENTE G, CHIUSA L, GEUNA M, NOVERO D,
PALESTRO G: MIB-1, Ki67, and PCNA scores and DNA flow cytom-
etry in intermediate grade malignant lymphomas. J Clin Pathol
47:18—22, 1994
13. LAN HY, PATERSON DJ, ATKINS RC: Initiation and evolution of
interstitial leukocytic infiltration in experimental glomerulonephritis.
Kidney mt 40:425—433, 1991
14. LAN HY, NIKOLIC-PATERSON DJ, ZARAMA M, VANNICE JL, ATKINS
RC: Suppression of experimental glomerulonephritis by the IL-I
receptor antagonist. Kidney mt 43:479—485, 1993
15. LAN HY, MU W, NIKOLIC-PATERSON DJ, ATKINS RC: A novel, simple,
reliable and sensitive method of multiple immunoenzymic staining:
Use of microwave oven heating to block antibody cross-reactivity and
retrieve antigens. J Histochem Cytochem 43:97—102, 1995
16. DIJKSTRA CD, D0PP EA, JOLING P, KRAAL G: The heterogeneity of
mononuclear phagocytes in lymphoid organs: Distinct macrophage
subpopulations in the rat recognized by monoclonal antibodies ED!,
ED2, ED3. Immunology 54:589—599, 1985
17. HUING T, WALLNY HJ, HARTLEY JK, LAWETZTY A, TIEFENTHALER G:
A monoclonal antibody to a constant region of the rat T cell antigen
receptor that induces T cell activation. J Exp Med 169:73—86, 1989
18. SUNDERLAND CA, MCMASTER WR, WILLIAMS AF: Purification with
monoclonal antibody of a predominant leukocyte-common antigen
and glycoprotein from rat thymocytes. Eurflmmunol 9:155—159, 1979
19. WASEEM NH, LANE DP: Monoclonal antibody analysis of the prolif-
erating cell nuclear antigen (PCNA). J Cell Sci 96:121—129, 1990
20. ROSE DSC, MADDOX PH, BROWN CD: Which proliferation markers
for routine immunohistology? A comparison of five antibodies. J Clin
Pathol 47:1010—1014, 1994
21. LYNCH DAF, CLARKE AMT, JACKSON P, AXON ATR, DIXON MF,
QUIRKE P: Comparison of labelling by bromodeoxyuridine, MIB-1,
and proliferating cell nuclear antigen in gastric mucosal biopsy
specimens. J Cliii Pathol 47:122—125, 1994
22. LAN HY, NIKOLIC-PATERSON DJ, ATKINS RC: Trafficking of inflam-
matory macrophages to the draining kidney lymph node during
experimental glomerulonephritis. Clin Exp Immunol 92:336—34 1, 1993
23. JOHNSON RJ: The glomerular response to injury: Progression or
resolution? Kidney mt 45:1769—1782, 1994
24. DAMOISEAUX JGMC, D0PP EA, CALAME W, Co D, MACPI-mRSON
GG, DIJKSTRA CD: Rat macrophage lysosomal membrane antigen
recognised by monoclonal antibody ED!. Immunology 83:140—147,
1994
25. BACCARINI M, STANLEY ER: Colony stimulating factor-i, in Growth
Factors, Differentiation Factors, and Cytokines, edited by HABENICHT A,
Berlin, Heidelberg, Springer-Verlag, 1990, pp 188—199
26. BLOOM RD, FLORQUIN 5, SINGER GG, BRENNAN DC, RUBIN KELLEY
V: Colony stimulating factor-i in the induction of lupus nephritis.
Kidney lot 43:1000—1009, 1993
27. RUBIN KELLEY V, BLOOM RD, YUI MA, MARTIN C, PRICE D: Pivotal
role of colony stimulating factor-i in lupus nephritis. Kidney mt
45(Suppl 45):S83—S85, 1994
